Analyzing the market’s evolution in the aftermath of the COVID-19 pandemic, Maxer identified the opportunity to enhance its digital marketing offer for pharma companies.

In particular, Maxer proposes:

• Actions in support of medical reps: effective communication on virtual channels
• Actions in support of products: increase in Share of Voice and Share of Science
• Promotion on unmet physicians: increase in the number of contacts with physicians
• Digital profiling of physician: associate homogeneous groups of doctors and communicate with them through the most effective and appreciated media.